Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
88.50    0.00 (0.00%)
Bid:
87.00
Ask:
90.00
Spread: 3.00 (3.448%)
Market Cap: £12.83m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Contract Gain

11 Apr 2006 07:30

Adventis Group PLC11 April 2006 For release Adventis Group plc ("Adventis") Contract Gain Adventis ("ATG/L"), the multimedia marketing and advertising agency, announcesthat Affiniti UK Ltd, its Bucks-based healthcare agency has been appointed bySanofi Pasteur MSD, an existing client, to work on a campaign for a new vaccinethat could protect the elderly against shingles. An attack of shingles can be extremely painful, with around a quarter ofsufferers going on to develop post herpetic neuralgia, an often debilitatingillness which can last for months or even years. In the UK, about 250,000 peoplesuffer from shingles each year, almost half of these being over 60 years old. Affiniti won this 3-way pitch with a strong strategic approach, which furtherextends their vaccine product portfolio. Commenting, Affiniti MD, Stuart Tennant, said: "Everyone in the agency isdelighted. We continue to build market share in the healthcare sector," whereas,Charles Phillpot, Adventis CEO said in his statement for the year ended 31December 2005: "Revenue by sector grew over that achieved in the previous year." - ENDS - Editor's NotesAdventis Group plc is an AIM listed, full service marketing and advertisingagency, providing services to the property, healthcare and financial servicesindustries.Through its six operating companies the company provides a complete range ofcommunication services, including corporate identity programmes, advertisingcampaigns, media planning & buying, literature, public relation, packaging,exhibitions, research and planning, interiors, signage and digital media.Adventis employs over 80 staff in London and the South East.www.adventis.co.uk In January 2005, Adventis acquired Affiniti (UK) Ltd, a specialised UKhealthcare advertising agency with clients such as Allergan, Sanofi Pasteur MSD,Chiron Vaccines, Eden Biopharm, Leo Pharma and Serono. The acquisition hasperformed very well in 2005 with a pre-tax profit of £247,000 and builds on thefoothold Adventis Group already had in this profitable market. Enquiries: Adventis Group plcCharles Phillpot, Chief Executive Officer 020 7034 4750 Affiniti (UK) LtdStuart Tennant, Managing Director 01494 775 213 Seymour PierceJohn Depasquale 020 7107 8000 Binns & Co PR Ltd 020 7786 9600Peter Binns 07768 392 582Annie Evangeli 07778 507 162 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 202611:26 amRNSStandard form for notification of major holdings
3rd Jun 20267:07 amRNSExclusivity Agreement with Zenith Energy
27th May 202612:09 pmRNSDirector/PDMR Shareholding
15th May 202612:25 pmRNSStandard form for notification of major holdings
14th May 20267:00 amRNSIssue of Equity and Total Voting Rights
7th May 20262:42 pmRNSShare Consolidation Effective
1st May 202610:15 amRNSDirector/PDMR Shareholding
27th Apr 20263:57 pmRNSResults of General Meeting & TVR
23rd Apr 20266:03 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSClarification of media article
10th Apr 20269:11 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20264:41 pmRNSProposed Placing to raise £1.1 million
13th Mar 20267:00 amRNSFunding from Group of Strategic Investors
13th Mar 20267:00 amRNSFunding from Group of Strategic Investors
9th Mar 20267:00 amRNSBeacon Acquisition and Commencement of Trading
18th Feb 20267:06 amRNSPublication of Beacon Admission Document
16th Feb 202611:30 amRNSWest Newton Update
5th Feb 20267:18 amRNSReabold Notes Beacon Announcement
13th Jan 202611:53 amRNSStandard form for notification of major holdings
12th Jan 20267:00 amRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSPublication of Favourable Formal Decree
24th Dec 20257:00 amRNSStandard form for notification of major holdings
14th Nov 20257:00 amRNS-RReabold launches new interactive investor hub
24th Oct 20257:00 amRNSDanube - Parta Licence Update
10th Oct 20257:00 amRNSFurther Investment into LNEnergy
7th Oct 20257:56 amRNS€16 Million Earn Out Agreed for Colle Santo
30th Sep 20257:00 amRNSUnaudited Interim Results
26th Aug 20257:00 amRNSKey Regulatory Milestone Achieved for Colle Santo
7th Aug 20257:00 amRNSOperations Update on West Newton
11th Jul 20251:11 pmRNSResults of Annual General Meeting
16th Jun 202512:31 pmRNSDirector/PDMR Dealings
13th Jun 20254:02 pmRNSPublication of Annual Report and Notice of AGM
13th Jun 202511:57 amRNSDeferred Annual Bonus Plan 2024 Share Option Award
11th Jun 20257:00 amRNSFY Results for the year ended 31 December 2024
8th May 20257:24 amRNSConversion of Loan Notes
26th Mar 20257:00 amRNSUpdate on Colle Santo, Italy
17th Mar 20257:00 amRNSAppointment of NED to the Board of Rathlin Energy
4th Mar 202510:10 amRNSHolding(s) in Company
4th Mar 202510:09 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSCompletion of Further Investment in Rathlin Energy
30th Jan 20257:00 amRNSLNEnergy Option Extension
12th Dec 20247:00 amRNSFurther investment in Rathlin Energy
24th Oct 20247:00 amRNSConversion of Loan Notes
8th Oct 20247:00 amRNSChange of Nominated Adviser
26th Sep 20247:00 amRNSUnaudited Interim Results
24th Sep 20247:00 amRNSWest Newton Update
20th Aug 20247:00 amRNSLNEnergy Update
28th Jun 202411:47 amRNSResult of AGM
17th Jun 202411:15 amRNSDirector/PDMR Dealing
14th Jun 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.